Volver a Agenda
Session Chair(s)
Atsushi Tsukamoto, PHD, MSC
Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
Learning Objective : Effectively lead and manage a West and East Asian hybrid drug development team; Discuss various leadership models in a hybrid team; Discuss strengths and weaknesses of a hybrid team, especially a West and East Asian hybrid; Identify success factors for Western colleagues to effectively work with Korean, Chinese and Japanese organizations in a global environment.
Speaker(s)
Panelist
Robert Hilke, MA
Hilke Communications Corporation, Japan
Chief Executive Officer
Panelist
Gareth Julian Monteath, PHD, MBA, MS
Link Global Solution Inc., Japan
Executive Director
Panelist
Atsushi Tsukamoto, PHD, MSC
Daiichi Sankyo, United States
Head is Therapeutic Area Strategies
¿Tiene una cuenta?